-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WuTXn7fX9sbquxszx+LyvhCc4EJkMm6SNxJeUxUoe8Rw/LFI2SMHqaaK2XP9lvrD HdUeKVu1n9F+Y8qnNSnolg== 0001005477-98-000101.txt : 19980128 0001005477-98-000101.hdr.sgml : 19980128 ACCESSION NUMBER: 0001005477-98-000101 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19980116 ITEM INFORMATION: FILED AS OF DATE: 19980127 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/ CENTRAL INDEX KEY: 0000946486 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171943 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: SEC FILE NUMBER: 000-26422 FILM NUMBER: 98514295 BUSINESS ADDRESS: STREET 1: 509 MADISON AVE 14TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2122239504 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: STE 435 CITY: SOUTH SAN FRANCSICO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961121 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN INC DATE OF NAME CHANGE: 19950609 8-K/A 1 AMENDMENT NO. 1 TO FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 --------------------------- FORM 8-K/A AMENDMENT NO. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 16, 1998 Date of Report (Date of earliest event reported) DISCOVERY LABORATORIES, INC. (Exact name of Registrant as specified in its charter) Delaware 000-26422 94-3171943 (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification Number) 509 Madison Avenue, 14th Floor New York, New York 10022 (Address of principal executive offices) (212) 223-9504 (Registrant's telephone number, including area code) This Amendment No. 1 to the Current Report of Discovery Laboratories, Inc. (the "Company") on Form-8-K dated January 16, 1998 relates to a change in the Company's certifying accountant. The purpose of this Amendment is to amend Item 4 to provide that with respect to the interim period from December 31, 1996 through January 16, 1998, the Company believes that there were no disagreements with the former accountants as described in Item 304(a)(1)(iv) of Regulation S-B. Item 4. Changes in Registrant's Certifying Accountant On January 16, 1998, the Audit Committee of the Company retained Richard A. Eisner & Company, LLP ("RAE"), as the independent accountants to audit the Company's financial statements for fiscal year 1997. Prior to the merger of Discovery Laboratories, Inc., a former Delaware corporation ("Old Discovery"), with and into the Company (the "Merger"), which Merger became effective on November 25, 1997, RAE served as the independent accountants for Old Discovery. In connection with the Merger, the Company's executive offices and principal accounting functions were consolidated with Old Discovery's and, accordingly, the Company has determined to maintain the professional relationship established with RAE by Old Discovery. On January 16, 1998, the Company advised Ernst & Young, LLP ("Ernst & Young"), the Company's previous independent accountants, that the Company would not be retaining Ernst & Young to audit the Company's financial statements for fiscal year 1997. The Company believes that, with respect to the fiscal years ended December 31, 1997 and 1996, and the subsequent interim period through January 16, 1998, the Company did not have any disagreement on any matter of accounting principals or practices, financial statement disclosure or auditing scope or procedure, which disagreement, if not resolved to the satisfaction of Ernst & Young would have caused it to make reference in connection with its report on the Company's financial statements to the subject matter of the disagreement. The 1995 and 1996 audit reports issued by Ernst & Young for the Company did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles. However, in reissuing its audit report on the Company's 1996 financial statements in connection with the filing by the Company of its registration statement on Form S-4 filed with the Securities and Exchange Commission on August 25, 1997 (and the amendments thereto), Ernst & Young added an explanatory paragraph to such report with respect to the ability of the Company to continue as a going concern. During those years there were no events described in Item 304(a)(1)(iv) (B) of Regulation S-B promulgated under the Act. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DISCOVERY LABORATORIES, INC. Date: January 27, 1998 By: /s/ James S. Kuo, M.D. ------------------------------------- Name: James S. Kuo, M.D. Title: Chief Executive Officer Exhibit Index Exhibit Number Description -------------- ----------- 16.1* Letter on Change in Certifying Accountant - -------- * Supersedes such exhibit as previously filed with Form 8-K dated January 16, 1998 filed with the Commission on January 20, 1998. EX-16.1 2 LETTER RE: CHANGE OF CERTIFYING ACCOUNTANT EXHIBIT 16.1 January 26, 1998 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Gentlemen: We have read Item 4 of Form 8-K/A dated January 16, 1998, of Discovery Laboratories, Inc. and are in agreement with the statements contained therein, with the exception of the first sentence of the first paragraph on which we have no basis to agree or disagree. /s/ ERNST & YOUNG LLP --------------------- -----END PRIVACY-ENHANCED MESSAGE-----